How do I differentiate mild, moderate, and severe facial and oral movements on the Abnormal Involuntary Movement Scale (AIMS)?

Differentiating Mild, Moderate, and Severe Facial and Oral Movements on AIMS

On the AIMS scale, mild facial/oral movements are scored as 2 (minimal movements that may be extreme normal), moderate movements are scored as 3 (movements that are clearly abnormal but not disabling), and severe movements are scored as 4 (movements that are incapacitating or disabling). 1

AIMS Scoring Framework

The AIMS uses a 0-4 point scale for each body region, where:

• 0 = None (no movements)
• 1 = Minimal (may be extreme normal)
• 2 = Mild (clearly abnormal but not disabling)
• 3 = Moderate (movements are obvious and may interfere with function)
• 4 = Severe (movements are incapacitating or disabling)

Key Distinctions for Facial and Oral Movements

Mild (Score = 2)

• Movements are clearly present but subtle
• Patient may be unaware of the movements 2
• Movements do not interfere with daily function
• Typically orofacial in location 2
• Noticeable to trained observers but may not be obvious to casual observers

Moderate (Score = 3)

• Movements are obvious and readily apparent
• May cause some functional interference (e.g., difficulty speaking clearly, eating)
• Patient is often aware of the movements
• Movements occur with greater frequency and amplitude 3

Severe (Score = 4)

• Movements are incapacitating or disabling
• Significantly impair daily activities (eating, speaking, social interaction)
• Movements are constant or nearly constant
• May cause social distress or isolation

Critical Assessment Dimensions

When rating AIMS, you must evaluate three separate dimensions that are not explicitly captured in the standard AIMS scoring but are essential for accurate assessment 3:

1. Quality - The type/character of the movement
2. Frequency - How often the movement occurs
3. Amplitude - The extent/range of the movement

Common Pitfalls to Avoid

• Experience matters: Inter-rater reliability is significantly higher among experienced raters 3. If you're new to AIMS, seek supervision or training.
• Context is essential: The AIMS is not specific for tardive dyskinesia 4. Abnormal movements can occur in neuroleptic-naive patients (12.6% prevalence in children) 2.
• Patient awareness varies: Patients with mild movements are typically unaware of them 2, so don't rely solely on patient report.
• Multiple analyses recommended: No single AIMS score defines clinical significance; consider effect size, response analyses, and category shifts 5.

Practical Clinical Application

For defining tardive dyskinesia: Requires at least mild movements (score ≥2) in ≥2 anatomical areas, OR moderate or greater movements (score ≥3) in ≥1 area 1. This criterion shows 96% agreement between different rating scales 1.

Timing of assessment: Conduct AIMS within the context of ongoing treatment and as part of informed consent for neuroleptic medications 4. Regular follow-up assessments are necessary to monitor progression 6.